Algeta ASA: Algeta announces change to Financial Calendar

Oslo, Norway, 20 January 2014 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces an update to its financial calendar. The fourth quarter and full year 2013 results will now be published on 5 February 2014, and not on 28 February 2014 as stated in the announcement of 6 November 2013. ### For further information, please contact: Oystein Soug +47 90 65 65 25 Chief Financial Officer Mike Booth +1 646 410 1884 Communications & Corporate Affairs About Algeta Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Change to financial calendar: This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Algeta ASA via GlobeNewswire [HUG#1755605]